26.8 C
New York
Thursday, July 3, 2025

Tag: EQT

newssourcecompanyFORcontentinformation1marketbusiness

EQT to acquire Europa Biosite, a distributor of life science products

EQT Healthcare Growth to acquire Europa Biosite, a distributor of over ten million high-quality life science reagents to academic and biopharma researchers across Europe...

EQT Corporation Schedules Second Quarter 2025 Earnings Release and Conference Call

PITTSBURGH, July 2, 2025 /PRNewswire/ -- EQT Corporation (NYSE: EQT) plans to issue its second quarter financial and operating results news release after market...

EQT Real Estate acquires 2 million square foot logistics portfolio in Northern California’s Central Valley

Four-building, Class A industrial portfolio totals 2.04 million square feet in Manteca, California  Located near major highways and an intermodal rail terminal, the properties...

EQT Real Estate acquires 2 million square foot logistics portfolio in Northern California’s Central Valley

Four-building, Class A industrial portfolio totals 2.04 million square feet in Manteca, California  Located near major highways and an intermodal rail terminal, the properties...

EQT to sell Pioneer Corporation, a leading Japanese provider of in-car sound and multimedia products and solutions, to CarUX for USD 1.1 billion

EQT to sell Pioneer, a leading Japanese provider of in-car sound and multimedia products and solutions for global OEMs and the consumer aftermarket, for...

EQT Releases 2024 ESG Report, “Promises Made, Promises Delivered”

Company Marks Milestone as World's First Large-Scale Traditional Energy Producer to Achieve Net Zero Scope 1 & 2 Greenhouse Gas Emissions PITTSBURGH, June 24, 2025...

EQT sets target fund size for EQT XI at EUR 23 billion

THIS IS INFORMATION THAT EQT AB (PUBL) IS OBLIGED TO MAKE PUBLIC PURSUANT TO THE EU MARKET ABUSE REGULATION. THE INFORMATION WAS SUBMITTED FOR...

EQT Life Sciences Co-Leads USD 135 Million Series B Financing in SpliceBio

Financing was co-led by EQT Life Sciences and Sanofi Ventures, with participation from Roche Venture Fund, as well as all existing investorsProceeds will support...

EQT Life Sciences Leads USD 80 Million Series A Funding Round in Mosanna Therapeutics to Advance Sleep Apnea Nasal Spray

Series A Funding will be used to advance Mosanna's nasal spray therapy through Phase 2 Clinical TrialsBiotech veteran David Weber has been appointed CEO...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsEQT

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers